首页 | 本学科首页   官方微博 | 高级检索  
     

低分子肝素钙治疗不稳定心绞痛的疗效观察
引用本文:任节,毛建华,段宝祥. 低分子肝素钙治疗不稳定心绞痛的疗效观察[J]. 中国冶金工业医学杂志, 2004, 21(3): 178-179
作者姓名:任节  毛建华  段宝祥
作者单位:1. 南京医科大学附属马钢医院心内科,安徽,马鞍山,243000
2. 南京医科大学
摘    要:
目的:观察低分子肝素钙对不稳定心绞痛(UAP)的疗效和安全性。方法:76例UAP患者随机分为观察组和对照组,观察组给以低分子肝素钙注射液每12小时1次皮下注射,剂量为0.1 ml/10 kg,通常疗程为10天。两组同时应用常规治疗:卧床休息、供氧、鲁南欣康20 mg加入生理盐水250 ml静脉滴注,1日1次,共用7天等,观察疗效及出血并发症。结果:观察组无严重出血并发症,临床总有效率90.1%,而对照组总有效率68.6%(P<0.01),观察组疗效明显优于对照组。结论:低分子肝素钙(速碧林)治疗不稳定心绞痛,疗效肯定。

关 键 词:低分子 肝素钙 不稳定心绞痛 并发症 UAP
文章编号:1005-5495(2004)03-0178-02
修稿时间:2003-11-25

The clinical observation of low molecular weight heparin in the treating unstable angina pectoris
. REN Jie,MAO Jian-hua,DUAN Bao-xiang. Hospitalof MISCO,Ma Anshan. The clinical observation of low molecular weight heparin in the treating unstable angina pectoris[J]. Chinese Medical Journal of Metallurgical Industry, 2004, 21(3): 178-179
Authors:. REN Jie  MAO Jian-hua  DUAN Bao-xiang. Hospitalof MISCO  Ma Anshan
Affiliation:. REN Jie,MAO Jian-hua,DUAN Bao-xiang. Hospitalof MISCO,Ma Anshan 243000
Abstract:
Objective:To observe clinical therapeatic effectiveness of fraxiparine in treating unstable angina pectoris. Methods:76 cases of unstable angina pectoriswere randomly allocated into the control group (of normal treatment) and treating group ( normal treatment combined with fraxiparine) the therapeatic course was 10 days. Results:The effective rate was 90.1% in the treating group and 68.6% in the control group( P < 0.01) , No obvious adverse reaction happened in the treating group.Conclusions:Low molecular weight heparin is clearly effective on unstable angina pectoris.
Keywords:Low molecular weight heparin Unstable angina pectoris
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号